Virtual Medicinal Product (VMP) - Triptorelin 11.25mg powder and solvent for prolonged-release suspension for injection vials

Navigation

Name Details

Name Start Date End Date
Name Current Name Triptorelin 11.25mg powder and solvent for prolonged-release suspension for injection vials Start Date 01-01-2025 End Date
Previous Name Previous Name Triptorelin 11.25mg powder and solvent for suspension for injection vials Start Date 15-08-2017 End Date 31-12-2024
Abbreviated Name Abbreviated Name Triptorelin 11.25mg inj vials Start Date 15-08-2017
Previous Abbreviated Name Triptorelin acetate 11.25mg inj vials Previous Start Date 15-11-2012 Previous End Date 14-08-2017

Unit Dose & Form Information

DF Indicator
Discrete
UDFS Indicator
1.0
UDFS UOM
vial
Unit Dose UOM
vial

Summary

Prescribing Status
Valid as a prescribable product
Controlled Drug Category
No Controlled Drug Status
Route
Intramuscular
Form
Powder and solvent for prolonged-release suspension for inj
Ontology Form/Route
suspensioninjectionprolonged-release.intramuscular
Name Basis
rINN - Recommended International Non-proprietary

Codes

ATC Code
L02AE04
BNF Start Date End Date
Current BNF 08030402 Start Date 04-04-2022 End Date
Previous BNF 08030402 Start Date 14-02-2005 End Date 03-04-2022
Previous BNF 06070200 Start Date 14-02-2005 End Date 03-04-2022
SNOMED Codes
Code Start Date End Date
36145111000001106 05-11-2018
410961006 10-08-2005 04-11-2018
8175811000001109 27-10-2004 09-08-2005

VMP Ingredients

VMP ingredients table
Name Basis of Strength Description BOSS Strength and UOM (Nmr) Strength and UOM (Dmr)
Triptorelin Based on Ingredient Substance 11.25 mg

Parent Products

Virtual Medicinal Product Pack (VMPP) Information

Pack Size Drug Tariff Price Drug Tariff Payment Category
1 vial 20700 Part VIIIA Category C